Sectra AB (publ) (SECT-B.ST)
SEK 274.8
(0.15%)
SEK 274.8
(0.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -772.85 Million SEK | -4.02% |
| 2022 | -742.98 Million SEK | 0.43% |
| 2021 | -746.15 Million SEK | -95.63% |
| 2020 | -381.4 Million SEK | -47.9% |
| 2019 | -257.88 Million SEK | 14.17% |
| 2018 | -300.45 Million SEK | -18.17% |
| 2017 | -254.25 Million SEK | -0.8% |
| 2016 | -252.23 Million SEK | -16.07% |
| 2015 | -217.31 Million SEK | 27.1% |
| 2014 | -298.1 Million SEK | 31.6% |
| 2013 | -435.85 Million SEK | 14.5% |
| 2012 | -509.78 Million SEK | 9.83% |
| 2011 | -565.36 Million SEK | -167.51% |
| 2010 | -211.34 Million SEK | -9.49% |
| 2009 | -193.02 Million SEK | -4.8% |
| 2008 | -184.18 Million SEK | 36.1% |
| 2007 | -288.24 Million SEK | 25.16% |
| 2006 | -385.15 Million SEK | 7.04% |
| 2005 | -414.29 Million SEK | -35.26% |
| 2004 | -306.3 Million SEK | -4.76% |
| 2003 | -292.38 Million SEK | -106.01% |
| 2002 | -141.92 Million SEK | -31.76% |
| 2001 | -107.71 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -653.47 Million SEK | 15.45% |
| 2023 Q1 | -610.21 Million SEK | 17.87% |
| 2023 Q4 | -772.85 Million SEK | -16.31% |
| 2023 Q3 | -664.46 Million SEK | -41.44% |
| 2023 Q2 | -469.78 Million SEK | 23.01% |
| 2023 FY | -772.85 Million SEK | -4.02% |
| 2022 Q3 | -402.07 Million SEK | -8.69% |
| 2022 FY | -742.98 Million SEK | 0.43% |
| 2022 Q2 | -369.91 Million SEK | 44.52% |
| 2022 Q1 | -666.69 Million SEK | 10.65% |
| 2022 Q4 | -742.98 Million SEK | -84.79% |
| 2021 Q1 | -370.36 Million SEK | 2.89% |
| 2021 Q2 | -395.37 Million SEK | -6.75% |
| 2021 Q3 | -357.22 Million SEK | 9.65% |
| 2021 Q4 | -746.15 Million SEK | -108.88% |
| 2021 FY | -746.15 Million SEK | -95.63% |
| 2020 FY | -381.4 Million SEK | -47.9% |
| 2020 Q1 | -352.17 Million SEK | -36.56% |
| 2020 Q3 | -290.62 Million SEK | -52.99% |
| 2020 Q2 | -189.96 Million SEK | 46.06% |
| 2020 Q4 | -381.4 Million SEK | -31.24% |
| 2019 Q3 | 275.56 Million SEK | 350.83% |
| 2019 Q2 | -109.86 Million SEK | 41.09% |
| 2019 Q1 | -186.47 Million SEK | 37.94% |
| 2019 FY | -257.88 Million SEK | 14.17% |
| 2019 Q4 | -257.88 Million SEK | -193.58% |
| 2018 Q1 | -263.44 Million SEK | -3.61% |
| 2018 Q3 | -259.47 Million SEK | -60.94% |
| 2018 Q4 | -300.45 Million SEK | -15.8% |
| 2018 FY | -300.45 Million SEK | -18.17% |
| 2018 Q2 | -161.22 Million SEK | 38.8% |
| 2017 Q1 | -221.38 Million SEK | 12.23% |
| 2017 FY | -254.25 Million SEK | -0.8% |
| 2017 Q3 | -167.25 Million SEK | -79.01% |
| 2017 Q2 | -93.42 Million SEK | 57.8% |
| 2017 Q4 | -254.25 Million SEK | -52.02% |
| 2016 Q1 | -197.95 Million SEK | 8.91% |
| 2016 FY | -252.23 Million SEK | -16.07% |
| 2016 Q3 | -165.03 Million SEK | -168.23% |
| 2016 Q2 | -61.52 Million SEK | 68.92% |
| 2016 Q4 | -252.23 Million SEK | -52.84% |
| 2015 Q3 | -146.63 Million SEK | -54.16% |
| 2015 Q2 | -95.12 Million SEK | 64.02% |
| 2015 Q1 | -264.38 Million SEK | 11.31% |
| 2015 Q4 | -217.31 Million SEK | -48.19% |
| 2015 FY | -217.31 Million SEK | 27.1% |
| 2014 Q4 | -298.1 Million SEK | -46.35% |
| 2014 Q3 | -203.69 Million SEK | 28.47% |
| 2014 Q2 | -284.76 Million SEK | 34.45% |
| 2014 Q1 | -434.45 Million SEK | 0.32% |
| 2014 FY | -298.1 Million SEK | 31.6% |
| 2013 Q4 | -435.85 Million SEK | -7.32% |
| 2013 Q1 | -492.59 Million SEK | 3.37% |
| 2013 Q2 | -367.13 Million SEK | 25.47% |
| 2013 Q3 | -406.14 Million SEK | -10.62% |
| 2013 FY | -435.85 Million SEK | 14.5% |
| 2012 Q1 | -600.76 Million SEK | -6.26% |
| 2012 Q3 | -492 Million SEK | -23.51% |
| 2012 Q4 | -509.78 Million SEK | -3.61% |
| 2012 FY | -509.78 Million SEK | 9.83% |
| 2012 Q2 | -398.36 Million SEK | 33.69% |
| 2011 Q2 | -687.86 Million SEK | -291.41% |
| 2011 Q1 | -175.74 Million SEK | 16.84% |
| 2011 FY | -565.36 Million SEK | -167.51% |
| 2011 Q4 | -565.36 Million SEK | -0.37% |
| 2011 Q3 | -563.28 Million SEK | 18.11% |
| 2010 Q4 | -211.34 Million SEK | -11.29% |
| 2010 FY | -211.34 Million SEK | -9.49% |
| 2010 Q3 | -189.9 Million SEK | -21.97% |
| 2010 Q1 | -174.56 Million SEK | 9.56% |
| 2010 Q2 | -155.7 Million SEK | 10.8% |
| 2009 Q4 | -193.02 Million SEK | 0.0% |
| 2009 FY | -193.02 Million SEK | -4.8% |
| 2008 FY | -184.18 Million SEK | 36.1% |
| 2007 FY | -288.24 Million SEK | 25.16% |
| 2006 FY | -385.15 Million SEK | 7.04% |
| 2005 FY | -414.29 Million SEK | -35.26% |
| 2004 FY | -306.3 Million SEK | -4.76% |
| 2003 FY | -292.38 Million SEK | -106.01% |
| 2002 FY | -141.92 Million SEK | -31.76% |
| 2001 FY | -107.71 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | -2098.788% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 162.992% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 162.992% |
| Arcoma AB | -1.12 Million SEK | -68415.248% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 803.347% |
| BICO Group AB (publ) | 927.9 Million SEK | 183.29% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 700.04% |
| CellaVision AB (publ) | -56.94 Million SEK | -1257.262% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | -5094.945% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | -9040.542% |
| C-Rad AB (publ) | -127.6 Million SEK | -505.683% |
| Duearity AB (publ) | 10.23 Million SEK | 7654.022% |
| Dignitana AB (publ) | 13.07 Million SEK | 6010.01% |
| Episurf Medical AB (publ) | -52.7 Million SEK | -1366.512% |
| Getinge AB (publ) | 5.4 Billion SEK | 114.291% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | -2104.804% |
| Iconovo AB (publ) | -10.75 Million SEK | -7085.755% |
| Integrum AB (publ) | -10.47 Million SEK | -7276.98% |
| Luxbright AB (publ) | -13.83 Million SEK | -5486.828% |
| Mentice AB (publ) | -49.56 Million SEK | -1459.301% |
| OssDsign AB (publ) | -162.78 Million SEK | -374.76% |
| Paxman AB (publ) | -11.41 Million SEK | -6672.868% |
| Promimic AB (publ) | -50.32 Million SEK | -1435.783% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 4152.711% |
| SciBase Holding AB (publ) | -27.32 Million SEK | -2728.473% |
| ScandiDos AB (publ) | -1.53 Million SEK | -50380.209% |
| Sedana Medical AB (publ) | -226.87 Million SEK | -240.653% |
| Senzime AB (publ) | -139.54 Million SEK | -453.853% |
| SpectraCure AB (publ) | -50.23 Million SEK | -1438.504% |
| Stille AB | -178.5 Million SEK | -332.961% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 162.936% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | -260.051% |